Return to Home

argenx SE

ARGX

Find Out if You Qualify for a Financial Reward by filling out the form below.

argenx SE Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On December 20, 2023, Investor’s Business Daily reported that argenx ‘s “stock crashed early Wednesday after its treatment for an autoimmune disease that causes skin blisters flopped in a Phase 3 study.” Based on this news, shares of the Company’s stock were down by more than 25% in intraday trading on the same day.

Find More Cases

Ticker Symbol Company Name Join Deadline
APLT Applied Therapeutics, Inc. February 18, 2025 Join
BIOA BioAge Labs, Inc. March 10, 2025 Join
PCRX Pacira BioSciences, Inc. March 14, 2025 Join
NVO Novo Nordisk A/S March 25, 2025 Join
GO Grocery Outlet Holding Corp. March 31, 2025 Join
NEM Newmont Corporation April 01, 2025 Join
GSK GSK plc April 07, 2025 Join
NTLA Intellia Therapeutics, Inc. April 14, 2025 Join
MRK Merck & Co., Inc. April 14, 2025 Join